What To Expect From Agilent's (A) Q4 Earnings

Life sciences tools company Agilent Technologies (NYSE:A) will be reporting earnings this Wednesday afternoon. Here’s what you need to know.

Agilent beat analysts’ revenue expectations last quarter, reporting revenues of $1.86 billion, up 9.4% year on year. It was a satisfactory quarter for the company, with a narrow beat of analysts’ revenue estimates.

Is Agilent a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting Agilent’s revenue to grow 7.4% year on year, improving from the 1.4% increase it recorded in the same quarter last year.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Agilent rarely misses Wall Street’s revenue estimates.

Looking at Agilent’s peers in the research tools & consumables segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Bio-Techne posted flat year-on-year revenue, beating analysts’ expectations by 2%, and Revvity reported revenues up 5.8%, topping estimates by 1.1%. Bio-Techne traded up 1.9% following the results while Revvity was down 7%.

Read our full analysis of Bio-Techne’s results here and Revvity’s results here.

The euphoria surrounding Trump’s November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the research tools & consumables stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.5% on average over the last month. Agilent is down 8.4% during the same time and is heading into earnings with an average analyst price target of $169.67 (compared to the current share price of $124.20).

Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.